Abstract
The induction of platelet aggregation by tumor cells was found to be an important determinant for the formation of metastasis of a highly metastatic variant of mouse colon adenocarcinoma 26. We found that the growth of highly metastatic clones, NL-17 and NL-33, of mouse colon 26 was well stimulated by platelet-derived growth factor (PDGF) and the stimulation was dependent on the concentration of the growth factor. The growth of weakly metastatic clones, NL-4 and NL-44, was stimulated marginally by PDGF. Other factors such as transforming growth factor beta and epidermal growth factor did not stimulate the growth of metastatic clones. As the amounts of the receptor of PDGF, as determined by [125I]PDGF binding and mRNA expression, were almost equal in NL-17 and NL-44 clones, the difference in growth potential of these clones after the treatment with PDGF could be explained by post-receptor mechanism(s). The present findings indicate that when tumor cells are arrested in a capillary through the formation of aggregates with platelets, PDGF might play an important role in the establishment of metastasis of mouse colon 26.
MeSH Terms
Adenocarcinoma/pathology,secondary
Animals
Blotting, Northern
Cell Division/drug effects
Clone Cells
Colonic Neoplasms/pathology
Humans
Mice
Platelet Aggregation/drug effects
Platelet-Derived Growth Factor/pharmacology
RNA, Messenger/analysis
Receptors, Cell Surface/genetics
Receptors, Platelet-Derived Growth Factor
Tumor Cells, Cultured
Chemicals
Platelet-Derived Growth Factor
RNA, Messenger
Receptors, Cell Surface
Receptors, Platelet-Derived Growth Factor
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Tsuruo T
Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo.
Watanabe M
Oh-hara T
References (14)
14 references, click to expand
-
Growth stimulating activity of lung extract on lung-colonizing colon 26 clones and its partial characterization.
Clin Exp Metastasis. 1988 Mar-Apr;6(2):131-9
PMID: 3345612
-
Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites.
Cancer Metastasis Rev. 1988 Jun;7(2):143-88
PMID: 3293836
-
Mechanisms of metastasis.
Biochim Biophys Acta. 1979 Feb 4;560(1):135-66
PMID: 367443
-
Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26.
Jpn J Cancer Res. 1989 Jan;80(1):51-8
PMID: 2540132
-
The pathogenesis of cancer metastasis.
Nature. 1980 Jan 10;283(5743):139-46
PMID: 6985715
-
Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors.
Nature. 1986 Sep 18-24;323(6085):226-32
PMID: 3020426
-
Metastatic but not primary melanoma cell lines grow in vitro independently of exogenous growth factors.
Int J Cancer. 1987 Nov 15;40(5):687-90
PMID: 3316051
-
Characterization of metastatic clones derived from a metastatic variant of mouse colon adenocarcinoma 26.
Cancer Res. 1983 Nov;43(11):5437-42
PMID: 6616476
-
Interaction of platelet-derived growth factor with its fibroblast receptor. Demonstration of ligand degradation and receptor modulation.
J Biol Chem. 1982 Apr 25;257(8):4216-21
PMID: 6279627
-
Tumor-induced platelet aggregation and growth promoting factors as determinants for successful tumor metastasis.
Clin Exp Metastasis. 1986 Jan-Mar;4(1):25-33
PMID: 3698366
-
Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary sites.
Biochim Biophys Acta. 1988 Nov 15;948(2):175-224
PMID: 3052592
-
Acquisition of metastatic ability in hybridomas between two low metastatic clones of murine colon adenocarcinoma 26 defective in either platelet-aggregating activity or in vivo growth potential.
Cancer Res. 1987 Aug 15;47(16):4396-401
PMID: 3607771
-
DNA-mediated transfer and cloning of a human multidrug-resistant gene of adriamycin-resistant myelogenous leukemia K562.
Cancer Res. 1987 May 15;47(10):2620-5
PMID: 3032411
-
The biology of cancer invasion and metastasis.
Adv Cancer Res. 1978;28:149-250
PMID: 360795